Anatara Lifesciences
(ASX) ANR
Anatara Lifesciences Financials at a Glance
Market Cap
$2.84M
Revenue (TTM)
$473.61K
Net Income (TTM)
$2.84M
EPS (TTM)
$-0.01
P/E Ratio
-1.55
Dividend
$0.00
Beta (Volatility)
-0.41 (Low)
Dividend
$0.00
Beta (Volatility)
-0.41 (Low)
Price
$0.01
Volume
210,888
Open
$0.01
Price
$0.01
Volume
210,888
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.00 - $0.02
Dividend
$0.00
Beta (Volatility)
-0.41 (Low)
Price
$0.01
Volume
210,888
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.00 - $0.02
ANR News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Anatara Lifesciences
Industry
Biotechnology
Sector
Health CareCEO
David Lionel Brookes, PhD
Website
anataralifesciences.comHeadquarters
Adelaide, VIC 3053, AU
ANR Financials
Key Financial Metrics (TTM)
Gross Margin
-55%
Operating Margin
-5%
Net Income Margin
-4%
Return on Equity
-105%
Return on Capital
-95%
Return on Assets
-69%
Earnings Yield
-64.52%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.84M
Shares Outstanding
315.95M
Volume
210.89K
Short Interest
0.00%
Avg. Volume
344.78K
Financials (TTM)
Gross Profit
$633.97K
Operating Income
$1.96M
EBITDA
$1.96M
Operating Cash Flow
$2.27M
Capital Expenditure
$3.00
Free Cash Flow
$2.27M
Cash & ST Invst.
$101.36K
Total Debt
$407.42K
Anatara Lifesciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$84.00
-100.0%
Gross Margin
0.00%
N/A
Market Cap
$2.84M
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$514.97K
+24.2%
EBITDA
$690.34K
+25.9%
Quarterly Fundamentals
Net Cash
$1.09M
+0.1%
Accounts Receivable
$206.12K
-29.5%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-68.76%
N/A
Return on Invested Capital
-95.47%
N/A
Free Cash Flow
$282.05K
+197.6%
Operating Cash Flow
$282.05K
+197.6%